CytoMed Therapeutics Ltd
F:F98
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CytoMed Therapeutics Ltd
F:F98
|
SG |
|
Bio-Techne Corp
NASDAQ:TECH
|
US |
|
E
|
Eimskipafelag Islands hf
ICEX:EIM
|
IS |
|
M
|
Mmcite as
PSE:MMCTE
|
CZ |
|
O
|
Ocr Group Bhd
KLSE:OCR
|
MY |
|
I
|
Index International Group PCL
SET:IND
|
TH |
|
P
|
Prakit Holdings PCL
SET:PRAKIT
|
TH |
|
M
|
Moneta Money Bank, A.s
PSE:MONET
|
CZ |
|
C
|
Comanche International PCL
SET:COMAN
|
TH |
|
I
|
Itthirit Nice Corporation PCL
SET:ITTHI
|
TH |
|
Telekom Malaysia Bhd
KLSE:TM
|
MY |
|
PTT Oil and Retail Business PCL
SET:OR
|
TH |
|
A
|
Asia Pramulia Tbk PT
IDX:ASPR
|
ID |
|
L
|
Lanebury Growth Capital Ltd
CNSX:LLL
|
CA |
|
M
|
M&T 1997 as
PSE:KLIKY
|
CZ |
|
D
|
Dynasty Ceramic PCL
SET:DCC
|
TH |
Bankruptcy Probability
CytoMed Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
CytoMed Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SG |
C
|
CytoMed Therapeutics Ltd
NASDAQ:GDTC
|
10.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
488.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
224.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
187.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
129.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
89.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
57.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
CytoMed Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, CytoMed Therapeutics Ltd has total debt of 391.7k SGD. This includes both short-term (0 SGD) and long-term (391.7k SGD) debt.
You can find a full breakdown on its Balance Sheet.